ENHANCED ACTIVITY OF HIV VACCINE USING A SECOND GENERATION IMMUNOMODULATORY OLIGONUCLEOTIDE

摘要

The invention relates to the therapeutic use of a second generation immunomodulatory oligonucleotide in combination with HIV-1 antigen or immunogen to enhance the ability to reduce the risk HIV infection and to control the progression of HIV infection to prevent AIDS Related Complex (ARC) and AIDS.